Research lays the foundation for developing obesity drugs based on enhancing β-AR signaling

Following up on a 2018 study that identified an epigenetic modifier known as histone deacetylase 11 (HDAC11) as a potential therapeutic target for treating obesity and diabetes, researchers from the University of Colorado School of Medicine have published new research that finds HDAC11 regulates G protein-coupled receptors (GPCRs) called beta-adrenergic receptors (β-ARs).

The…

Continue Reading


News Source: https://www.news-medical.net/news/20220214/Research-lays-the-foundation-for-developing-obesity-drugs-based-on-enhancing-ceb2-AR-signaling.aspx

Leave a comment